The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
To own Perpetua Resources, you really need to believe that Stibnite transitions from a long-permitted, pre-revenue story into a built mine with both gold and critical minerals relevance. The Hatch EPCM appointment and its US$4,000,000 equity stake give the execution plan more definition and align a key contractor with shareholders, which matters given the company is still unprofitable and expected to remain so for several years. The roughly US$71,200,000 equity raise and insider sales reinforce that funding will likely lean on dilution for now, even as government and Defense Department support highlight the antimony angle. The Idaho National Laboratory pilot plant pushes that antimony narrative forward in a tangible way, potentially becoming a short term catalyst, but it does not remove core risks around permitting follow through, construction costs, or future operating performance.
However, one funding-related risk here is easy to overlook and investors should be aware of it. Our valuation report unveils the possibility Perpetua Resources' shares may be trading at a premium.Explore 7 other fair value estimates on Perpetua Resources - why the stock might be worth as much as 10% more than the current price!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com